| Active ingredient (INN) | Paclitaxel |
|---|---|
| Brand names | Abraxane, ANZATAX paclitaxel |
| ATC level 5 | L01CD01 |
| ATC level 4 | L01CD |
| Therapeutic category | Auto-created by Therapeutic Goods Administration — Medicine Shortages scraper |
| WHO Essential Medicine | Yes (2023) |
| Controlled substance | No |
| Marketing-authorisation holders | Cipla Australia Pty Ltd, Fresenius Kabi Australia Pty Ltd, Hospira UK Limited, ACCORD HEALTHCARE LIMITED +7 more |
| Registrations on file | 26 |
| Patient information leaflet (PIL) | Not on file |
| Summary of product characteristics (SPC) | Not on file |
| Product | Strength | Form | Market | MA holder | Status |
|---|---|---|---|---|---|
| Apotex | 100 mg | — | 🇦🇺 AU | — | Active |
| NANOPACLICIP Paclitaxel | 100 mg | — | 🇦🇺 AU | Cipla Australia Pty Ltd | Active |
| CIPLA PACLITAXELPaclitaxel | 100 mg | — | 🇦🇺 AU | Cipla Australia Pty Ltd | Active |
| Kabi | 30 mg | — | 🇦🇺 AU | Fresenius Kabi Australia Pty Ltd | Active |
| Kabi | 100 mg | — | 🇦🇺 AU | Fresenius Kabi Australia Pty Ltd | Active |
| Kabi | 300 mg | — | 🇦🇺 AU | Fresenius Kabi Australia Pty Ltd | Active |
| PACLITAXEL 6MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION | 6MG | solution | 🇬🇧 GB | Hospira UK Limited | Active |
| PACLITAXEL 6 MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION | 6 MG | solution | 🇬🇧 GB | ACCORD HEALTHCARE LIMITED | Active |
| PACLITAXEL 6 MG/ ML, CONCENTRATE FOR SOLUTION FOR INFUSION. | 6 MG | solution | 🇬🇧 GB | ENNOGEN IP LTD | Active |
| ANZATAX paclitaxel | 150mg | — | 🇦🇺 AU | Pfizer Australia Pty Ltd | Active |
| ANZATAX paclitaxel | 30mg | — | 🇦🇺 AU | Pfizer Australia Pty Ltd | Active |
| ANZATAX paclitaxel | 300mg | — | 🇦🇺 AU | Pfizer Australia Pty Ltd | Active |
| Ebewe | 30 mg | — | 🇦🇺 AU | Sandoz Pty Ltd | Active |
| Ebewe | 100 mg | — | 🇦🇺 AU | Sandoz Pty Ltd | Active |
| Ebewe | 150 mg | — | 🇦🇺 AU | Sandoz Pty Ltd | Active |